XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (14,282) $ (4,326)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2 2
Stock-based compensation 382 376
Noncash interest expense 123
Gain on forgiveness of PPP Loan (42)
Arbitration settlement expense 1,500
Warrant modification expense 1,627
Warrants received as licensing fee (23)
Change in fair value of equity investment 6
Change in fair value of derivative liabilities 6,956 (513)
Other expense related to extension of warrants
Loss on extinguishment of derivative liability
Common stock payable to consultant 566
Gain on purchase of warrants (64)
Changes in operating assets and liabilities:    
Trade receivable (175) 86
Other accounts receivable and prepaid expenses 37 1
Inventory (30) (26)
Trade payables (59) 16
Other accounts payable and accrued expenses (265) 209
Deferred revenue (2) 199
Accrued severance pay, net (39)
Net cash used in operating activities (4,367) (3,391)
Cash flows from investing activities:    
Purchases of property plant and equipment (3) (2)
Net cash used in investing activities (3) (2)
Cash flows from financing activities:    
Proceeds from issuance of notes payable 42
Proceeds from note issued to related party 200
Payments of note payable to related party (200)
Proceeds from sale of common stock, net 9,479
Proceeds from exercise of warrants 4,968 1
Buy back of warrants from investor (388)
Net cash provided by financing activities 4,580 9,522
Effects of currency translation on cash (6) 66
Net increase in cash, cash equivalents and restricted cash 204 6,195
Cash, cash equivalents and restricted cash at beginning of period 7,533 1,338
Cash, cash equivalents and restricted cash at end of period 7,737 7,533
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for taxes
Supplemental non-cash financing and investing activities:    
Reclass warrants to non-derivative instruments
Discount on notes payable 123
Exchange of common stock into Preferred Stock 1
Shares issued from exercise of warrants previously classified as derivative liability 2,087 2,984
Reclass derivative liability to equity due to increase in authorized shares 8,706
Reclass equity to liability due to over issuance of shares 2,257
Reclass liability to equity after increase in authorized shares $ 2,257